プレスリリース

Illumina Posted a Stewardship-Focused Presentation for Investors

SAN DIEGO, Oct. 11, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) posted a stewardship-focused presentation for investors on the Events & Presentations section of its investor relations website, investor.illumina.com, on Wednesday, October 11, 2023. Members of Illumina's Board of Directors and senior management may use this presentation during meetings with investors. 

About Illumina

Illumina is improving human health by unlocking the power of the genome. In 2023, we celebrate 25 years of innovation, which has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, TikTok and YouTube.

Investors:
Salli Schwartz
+1.858.291.6421
ir@illumina.com

Media:
David McAlpine
+1.347.327.1336
pr@illumina.com

Cision View original content:https://www.prnewswire.com/news-releases/illumina-posted-a-stewardship-focused-presentation-for-investors-301954069.html

SOURCE Illumina, Inc.

最近の記事

イルミナが大きな成果の実現に向けてハンドルを握ります
Video: イルミナが大きな成果の実現に向けてハンドルを握ります
イルミナのCEO:課題に挑み、世界の医療を変革
イルミナのCEO:課題に挑み、世界の医療を変革
Emma Baple教授が、臨床研究における全ゲノムシーケンスの導入について語る
Video: Emma Baple教授が、臨床研究における全ゲノムシーケンスの導入について語る